These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23198686)

  • 21. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
    Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions.
    Joyce JG; Krauss IJ; Song HC; Opalka DW; Grimm KM; Nahas DD; Esser MT; Hrin R; Feng M; Dudkin VY; Chastain M; Shiver JW; Danishefsky SJ
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15684-9. PubMed ID: 18838688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
    Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
    Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120.
    Menendez A; Calarese DA; Stanfield RL; Chow KC; Scanlan CN; Kunert R; Katinger H; Burton DR; Wilson IA; Scott JK
    FASEB J; 2008 May; 22(5):1380-92. PubMed ID: 18198210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry.
    Platt EJ; Gomes MM; Kabat D
    Proc Natl Acad Sci U S A; 2012 May; 109(20):7829-34. PubMed ID: 22547820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gold manno-glyconanoparticles for intervening in HIV gp120 carbohydrate-mediated processes.
    Di Gianvincenzo P; Chiodo F; Marradi M; Penadés S
    Methods Enzymol; 2012; 509():21-40. PubMed ID: 22568899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proline is not uniquely capable of providing the pivot point for domain swapping in 2G12, a broadly neutralizing antibody against HIV-1.
    Gach JS; Furtmüller PG; Quendler H; Messner P; Wagner R; Katinger H; Kunert R
    J Biol Chem; 2010 Jan; 285(2):1122-7. PubMed ID: 19903812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120.
    Hoorelbeke B; van Montfort T; Xue J; LiWang PJ; Tanaka H; Igarashi Y; Van Damme EJ; Sanders RW; Balzarini J
    FEBS Lett; 2013 Apr; 587(7):860-6. PubMed ID: 23454641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Localization of the HIV-1 gp120 conformational epitope recognized by virus neutralizing monoclonal antibodies 2G12].
    Tumanova OIu; Kuvshinov VN; Il'ichev AA; Nekrasov BG; Ivanisenko VA; Kozlov AP; Sandakhchiev LS
    Mol Biol (Mosk); 2002; 36(4):657-63. PubMed ID: 12173470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans.
    Dunlop DC; Bonomelli C; Mansab F; Vasiljevic S; Doores KJ; Wormald MR; Palma AS; Feizi T; Harvey DJ; Dwek RA; Crispin M; Scanlan CN
    Glycobiology; 2010 Jul; 20(7):812-23. PubMed ID: 20181792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of a template-assembled oligomannose cluster as an epitope mimic for human HIV-neutralizing antibody 2G12.
    Li H; Wang LX
    Org Biomol Chem; 2004 Feb; 2(4):483-8. PubMed ID: 14770226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altering the Specificity of the Antibody Response to HIV gp120 with a Glycoconjugate Antigen.
    Liu CC; Zhai C; Zheng XJ; Ye XS
    ACS Chem Biol; 2016 Jun; 11(6):1702-9. PubMed ID: 27088577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electron microscopic and immunochemical analysis of the broadly neutralizing HIV-1-specific, anti-carbohydrate antibody, 2G12.
    Roux KH; Zhu P; Seavy M; Katinger H; Kunert R; Seamon V
    Mol Immunol; 2004 Aug; 41(10):1001-11. PubMed ID: 15302162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity.
    Doores KJ; Fulton Z; Hong V; Patel MK; Scanlan CN; Wormald MR; Finn MG; Burton DR; Wilson IA; Davis BG
    Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17107-12. PubMed ID: 20852065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic mimicry of the HIV envelope by AIDS-associated pathogens.
    Dunlop DC; Ulrich A; Appelmelk BJ; Burton DR; Dwek RA; Zitzmann N; Scanlan CN
    AIDS; 2008 Oct; 22(16):2214-7. PubMed ID: 18832887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
    Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
    J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High temperature SELMA: evolution of DNA-supported oligomannose clusters which are tightly recognized by HIV bnAb 2G12.
    Temme JS; MacPherson IS; DeCourcey JF; Krauss IJ
    J Am Chem Soc; 2014 Feb; 136(5):1726-9. PubMed ID: 24446826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward fully synthetic carbohydrate-based HIV antigen design: on the critical role of bivalency.
    Dudkin VY; Orlova M; Geng X; Mandal M; Olson WC; Danishefsky SJ
    J Am Chem Soc; 2004 Aug; 126(31):9560-2. PubMed ID: 15291558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12.
    Pantophlet R; Wilson IA; Burton DR
    Protein Eng Des Sel; 2004 Oct; 17(10):749-58. PubMed ID: 15542540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.